Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Enzyme (MLN) vs PIVX (PIVX) Price & Performance

Price performance (Past 24H)

Key statistics

Enzyme vs PIVX — how do they compare? Enzyme trades at Rp30,212 (market cap Rp134,13M, Rp104,56M 24h volume), while PIVX trades at Rp311.75 (market cap Rp72,86M, Rp45,95M 24h volume). The key difference: Enzyme is the larger of the two by market cap, and Enzyme's circulating supply is 3,3M MLN versus 104,9M PIVX for PIVX. Which is the better fit depends on your goals — on Pluang, investors hold Enzyme for 29 Days and PIVX for 8 Days on average.

MLNPIVX
Market Cap
Rp134,13MRp72,86M
Volume (24h)
Rp104,56MRp45,95M
Circulating Supply
3,3M MLN104,9M PIVX
Typical Hold Time
29 Days8 Days

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Enzyme

Enzyme (MLN) shows limited market activity with a modest market cap of Rp134,13M and circulating supply of 3,3jt tokens. The asset demonstrates relatively low volatility with an average hold time of 29 days, suggesting stable holder behavior. Trading volumes appear subdued across exchanges, indicating limited speculative interest. No significant protocol upgrades or ecosystem developments have been reported recently, though the project continues to operate its decentralized asset management platform.

Overall outlook remains cautious due to limited liquidity and trading activity. Key opportunities include potential ecosystem growth in decentralized finance asset management, while major risks include low market depth, regulatory uncertainty for DeFi protocols, and competition from larger DeFi platforms. The token's utility within its native protocol remains its primary value driver.

PIVX

PIVX is currently trading at Rp322.72 with a market cap of Rp72.86M, showing bearish technical signals across moving averages and oscillators. The asset is trading below all key support levels (S3=346, S2=403, S1=447) with RSI indicators suggesting oversold conditions at RSI_6=22.57 and RSI_12=18.06. Hold time averages 8 days, indicating relatively short-term holding patterns among investors.

Overall outlook remains bearish with technical indicators heavily favoring selling pressure. Key opportunity lies in potential oversold bounce from current levels, while major risks include continued downward momentum and low liquidity. The neutral oscillator reading suggests potential for stabilization if buying interest emerges.

About Enzyme

Enzyme is an easy-to-use on-chain asset management system that enables access to digital assets and DeFi from one simple, unified app. It provides a front-to-back execution and order management system, which provides fully automated reporting, risk management, administration, governance and operations.

Read more on MLN

About PIVX

PIVX, launched in 2016, is a decentralized, open-source blockchain project governed by a community-driven DAO. It uses advanced cryptography to prioritize user financial data protection.

Read more on PIVX